|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
09/14/2017 |
$1.00 |
$1.04 |
$0.96 |
$0.98 |
99.50K | 09/15/2017 |
$0.97 |
$1.02 |
$0.97 |
$1.02 |
197.70K | 09/18/2017 |
$1.00 |
$1.12 |
$1.00 |
$1.09 |
471.30K | 09/19/2017 |
$1.10 |
$1.13 |
$1.03 |
$1.07 |
380.10K | 09/20/2017 |
$1.15 |
$1.16 |
$0.96 |
$0.97 |
305.20K |
|
Acer Therapeutics is a biopharmaceutical company developing a personalized immunotherapy with the potential to treat illnesses, including multiple sclerosis as well as other autoimmune diseases such as neuromyelitis optica (NMO). Co. has been developing OPX-212 as an autologous T-cell immunotherapy for the treatment of NMO. NMO is an autoimmune disorder in which immune system cells and antibodies attack astrocytes causing to the secondary destruction of nerve cells (axons) in the optic nerves and the spinal cord. OPX-212 is specifically tailored to each patient's immune response to a protein, aquaporin-4 expressed by astrocytes, which is the targeted antigen in NMO. | |
|
OPXA (OPXA) has the following price history information. Looking back at OPXA historical stock prices for the last five trading days, on September 14, 2017, OPXA opened at $1.00, traded as high as $1.04 and as low as $0.96, and closed at $0.98. Trading volume was a total of 99.50K shares. On September 15, 2017, OPXA opened at $0.97, traded as high as $1.02 and as low as $0.97, and closed at $1.02. Trading volume was a total of 197.70K shares. On September 18, 2017, OPXA opened at $1.00, traded as high as $1.12 and as low as $1.00, and closed at $1.09. Trading volume was a total of 471.30K shares. On September 19, 2017, OPXA opened at $1.10, traded as high as $1.13 and as low as $1.03, and closed at $1.07. Trading volume was a total of 380.10K shares. On September 20, 2017, OPXA opened at $1.15, traded as high as $1.16 and as low as $0.96, and closed at $0.97. Trading volume was a total of 305.20K shares.
OPXA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into OPXA shares, starting with a $10,000 purchase of OPXA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
09/20/2017 |
|
Start price/share: |
$15.36 |
|
End price/share: |
$0.97 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.68% |
|
Average Annual Total Return: |
-54.85% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$631.38 |
|
Years: |
3.47 |
|
|
|
Date |
Close |
09/14/2017 | $0.98 | 09/15/2017 | $1.02 | 09/18/2017 | $1.09 | 09/19/2017 | $1.07 | 09/20/2017 | $0.97 |
|
|